Interferon Beta Tx Shows No Benefit in ARDS

]]>(MedPage Today) -- ORLANDO--Treatment with IV interferon beta 1a (IFN-β-1a) for 6 days did not lead to improved mortality or fewer ventilator-free days among patients with moderate- to severe acute respiratory distress syndrome (ARDS...